28-Aug-2026
Business Wire (Fri, 28-Aug 6:45 AM ET)
GE Healthcare’s New Blood Pressure Algorithm Study: What Investors Should Watch
TipRanks (Thu, 27-Aug 12:30 PM ET)
GE Healthcare’s New Spectral CT Study: What Investors Should Watch
TipRanks (Wed, 26-Aug 12:31 PM ET)
GE HealthCare management to present at upcoming investor conference
Business Wire (Wed, 26-Aug 8:00 AM ET)
TipRanks (Tue, 25-Aug 6:40 AM ET)
Globe Newswire (Thu, 20-Aug 11:00 AM ET)
Globe Newswire (Thu, 20-Aug 9:00 AM ET)
Globe Newswire (Wed, 19-Aug 6:10 PM ET)
GE HealthCare appoints William Grogan as Chief Financial Officer
Business Wire (Tue, 18-Aug 9:00 AM ET)
GE HealthCare expands the LOGIQ e ultrasound platform with new LOGIQ e family
Business Wire (Tue, 4-Aug 9:00 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of August 28, 2026, GEHC stock price declined to $71.72 with 1,834,675 million shares trading.
GEHC has a beta of 0.92, meaning it tends to be less sensitive to market movements. GEHC has a correlation of 0.11 to the broad based SPY ETF.
GEHC has a market cap of $32.40 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $5 billion in Revenue and $1.13 earnings per share. This beat revenue expectation by $32 million and exceeded earnings estimates by $.09.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, QQQ, VO, IVV.
GEHC has underperformed the market in the last year with a price return of -2.5% while the SPY ETF gained +19.7%. However, in the short term, GEHC had mixed performance relative to the market. It has outperformed in the last 3 months, returning +14.2% vs +2.2% return in SPY. But in the last 2 weeks, GEHC shares have been beat by the market, returning -2.7% compared to an SPY return of -0.9%.
GEHC support price is $71.36 and resistance is $73.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.